Prognostic role of single-photon emission computed tomography (SPECT) imaging in myocardial viability

Current Opinion in Cardiology

Volumn 21, Issue 5, 2006, Pages 457-463

  Patel, Rajan A G ^a   Beller, George A ^a  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

Coronary artery disease; Myocardial viability; Prognosis; Radionucleotide imaging; Single photon emission computed tomography

Indexed keywords

ATROPINE; DOBUTAMINE; FLUORODEOXYGLUCOSE F 18; ISOTOPE; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; NITRATE; TETROFOSMIN TC 99M; THALLIUM 201;

ANGIOCARDIOGRAPHY; CARDIAC RESYNCHRONIZATION THERAPY; CONGESTIVE HEART FAILURE; CONVALESCENCE; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; FUNCTIONAL ASSESSMENT; HEART FUNCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FAILURE; HEART MUSCLE; HEART MUSCLE REVASCULARIZATION; HEART VENTRICLE REMODELING; HUMAN; ISCHEMIC HEART DISEASE; POSITRON EMISSION TOMOGRAPHY; PREDICTION AND FORECASTING; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SENSITIVITY AND SPECIFICITY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STEM CELL TRANSPLANTATION; TREATMENT OUTCOME; TREATMENT RESPONSE; VALIDITY;

CORONARY ARTERIOSCLEROSIS; CORONARY ARTERY DISEASE; HEART; HUMANS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; SENSITIVITY AND SPECIFICITY; TISSUE SURVIVAL; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; VENTRICULAR DYSFUNCTION, LEFT;

EID: 33747069644     PISSN: 02684705     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.hco.0000240582.83967.d8     Document Type: Review

References (70)

1. Gheorghiade M, Bonow RO. Chronic heart failure in the United States: a manifestation of coronary artery disease. Circulation 1998; 97:282-289.
2. 99mTc SPECT techniques. This article also cites studies demonstrating the prognostic utility of each of these methods for determining viability.
3. Slart RH, Bax JJ, van Veldhuisen DJ, et al. Imaging techniques in nuclear cardiology for the assessment of myocardial viability. Int J Cardiovasc Imaging 2006; 22:63-80. An outstanding summary of the current nuclear techniques used clinically and in research to assess viability. Various PET tracers and SPECT tracers are discussed in addition to DISA-SPECT and FDG-PET.
4. Bax JJ, Poldermans D, Elhendy A, et al. Sensitivity, specificity, and predictive accuracies of various noninvasive techniques for detecting hibernating myocardium. Curr Probl Cardiol 2001; 26:141-186.
5. Alfieri O, La Canna G, Giubbini R, et al. Recovery of myocardial function. The ultimate target of coronary revascularization. Eur J Cardiothorac Surg 1993; 7:325-330.
6. Bax JJ, Visser FC, Van Lingen A, et al. Comparison between 360 degrees and 180 degrees data sampling in thallium-201 rest-redistribution single-photon emission tomography to predict functional recovery after revascularization. Eur J Nucl Med 1997; 24:516-522.
7. Bax JJ, Cornel JH, Visser FC, et al. Comparison of fluorine-18-FDG with restredistribution thallium-201 SPECT to delineate viable myocardium and predict functional recovery after revascularization. J Nucl Med 1998; 39:1481-1486.
8. Charney R, Schwinger ME, Chun J, et al. Dobutamine echocardiography and resting-redistribution thallium-201 scintigraphy predicts recovery of hibernating myocardium after coronary revascularization. Am Heart J 1994; 128:864-869.
9. Cuocolo A, Nicolai E, Petretta M, et al. One-year effect of myocardial revascularization on resting left ventricular function and regional thallium uptake in chronic CAD. J Nucl Med 1997; 38:1684-1692.
10. 99mTc-tetrofosmin, and dobutamine magnetic resonance imaging for identifying hibernating myocardium. Circulation 1998; 98:1869-1874.
11. 201Tl emission tomography combined with cine magnetic resonance imaging. Nucl Med Commun 1999; 20:209-214.
12. Marzullo P, Parodi O, Reisenhofer B, et al. Value of rest thallium-201/technetium-99m sestamibi scans and dobutamine echocardiography for detecting myocardial viability. Am J Cardiol 1993; 71:166-172.
13. Marzullo P, Sambuceti G, Parodi O, et al. Regional concordance and discordance between rest thallium 201 and sestamibi imaging for assessing tissue viability: comparison with postrevascularization functional recovery. J Nucl Cardiol 1995; 2:309-316.
14. Matsunari I, Fujino S, Taki J, et al. Quantitative rest technetium-99m tetrofosmin imaging in predicting functional recovery after revascularization: comparison with rest-redistribution thallium-201. J Am Coll Cardiol 1997; 29:1226-1233.
15. Matsunari I, Fujino S, Taki J, et al. Significance of late redistribution thallium-201 imaging after rest injection for detection of viable myocardium. J Nucl Med 1997; 38:1073-1078.
16. Mori T, Minamiji K, Kurogane H, et al. Rest-injected thallium-201 imaging for assessing viability of severe asynergic regions. J Nucl Med 1991; 32:1718-1724.
17. Nagueh SF, Vaduganathan P, Ali N, et al. Identification of hibernating myocardium: comparative accuracy of myocardial contrast echocardiography, rest-redistribution thallium-201 tomography and dobutamine echocardiography. J Am Coll Cardiol 1997; 29:985-993.
18. Pace L, Perrone-Filardi P, Mainenti P, et al. Combined evaluation of rest-redistribution thallium-201 tomography and low-dose dobutamine echocardiography enhances the identification of viable myocardium in patients with chronic coronary artery disease. Eur J Nucl Med 1998; 25:744-750.
19. 201Tl tomography versus dobutamine echocardiography. Circulation 1996; 94:2712-2719.
20. 201Tl uptake and comparative prediction of recovery of function. Circulation 1997; 95:626-635.
21. 201Tl imaging in detection of myocardial viability and prediction of improvement in left ventricular function after coronary bypass surgery in patients with severely depressed left ventricular function. Circulation 1993; 87:1630-1641.
22. Sciagra R, Bisi G, Santoro GM, et al. Comparison of baseline-nitrate technetium-99m sestamibi with rest-redistribution thallium-201 tomography in detecting viable hibernating myocardium and predicting postrevascularization recovery. J Am Coll Cardiol 1997; 30:384-391.
23. Sciagra R, Santoro GM, Bisi G, et al. Rest-redistribution thallium-201 SPECT to detect myocardial viability. J Nucl Med 1998; 39:384-390.
24. Senior R, Glenville B, Basu S, et al. Dobutamine echocardiography and thallium-201 imaging predict functional improvement after revascularisation in severe ischaemic left ventricular dysfunction. Br Heart J 1995; 74:358-364.
25. Sicari R, Varga A, Picano E, et al. Comparison of combination of dipyridamole and dobutamine during echocardiography with thallium scintigraphy with thallium scintigraphy to improve viability detection. Am J Cardiol 1999; 83:6-10.
26. 99mTc-sestamibi. Circulation 1994; 89:2552-2561.
27. Arnese M, Cornel JH, Salustri A, et al. Prediction of improvement of regional left ventricular function after surgical revascularization. A comparison of low-dose dobutamine echocardiography with 201Tl single-photon emission computed tomography. Circulation 1995; 91:2748-2752.
28. Bax JJ, Cornel JH, Visser FC, et al. Prediction of recovery of myocardial dysfunction after revascularization. Comparison of fluorine-18 fluorodeoxyglucose/ thallium-201 SPECT, thallium-201 stress-reinjection SPECT and dobutamine echocardiography. J Am Coll Cardiol 1996; 28:558-564.
29. Dilsizian V, Rocco TP, Freedman NM, et al. Enhanced detection of ischemic but viable myocardium by the reinjection of thallium after stress- redistribution imaging. N Engl J Med 1990; 323:141-146.
30. Gursurer M, Pinarli AE, Aksoy M, et al. Assessment of viable myocardium and prediction of postoperative improvement in left ventricular function in patients with severe left ventricular dysfunction by quantitative planar stress-redistribution-reinjection 201-T1 imaging. Int J Cardiol 1997; 58:179-184.
31. Haque T, Furukawa T, Takahashi M, Kinoshita M. Identification of hibernating myocardium by dobutamine stress echocardiography: comparison with thallium-201 reinjection imaging. Am Heart J 1995; 130:553-563.
32. Kostopoulos KG, Kranidis AI, Bouki KP, et al. Detection of myocardial viability in the prediction of improvement in left ventricular function after successful coronary revascularization by using the dobutamine stress echocardiography and quantitative SPECT rest-redistribution-reinjection 201TI imaging after dipyridamole infusion. Angiology 1996; 47:1039-1046.
33. Lipiecki J, Maublant JC, Citron B, et al. Comparable uptake of thallium-201 and technetium-99m MIBI in hibernating and "maimed" myocardium. Am J Cardiol 1997; 80:940-943.
34. Ohtani H, Tamaki N, Yonekura Y, et al. Value of thallium-201 reinjection after delayed SPECT imaging for predicting reversible ischemia after coronary artery bypass grafting. Am J Cardiol 1990; 66:394-399.
35. Taki J, Nakajima K, Matsunari I, et al. Assessment of improvement of myocardial fatty acid uptake and function after revascularization using iodine-123-BMIPP. J Nucl Med 1997; 38:1503-1510.
36. Tamaki N, Ohtani H, Yamashita K, et al. Metabolic activity in the areas of new fill-in after thallium-201 reinjection: comparison with positron emission tomography using fluorine-18-deoxyglucose. J Nucl Med 1991; 32:673-678.
37. Vanoverschelde JL, D'Hondt AM, Marwick T, et al. Head-to-head comparison of exercise-redistribution-reinjection thallium single-photon emission computed tomography and low dose dobutamine echocardiography for prediction of reversibility of chronic left ventricular ischemic dysfunction. J Am Coll Cardiol 1996; 28:432-442.
38. Kitsiou AN, Srinivasan G, Quyyumi AA, et al. Stress-induced reversible and mild-to-moderate irreversible thallium defects: are they equally accurate for predicting recovery of regional left ventricular function after revascularization? Circulation 1998; 98:501-508.
39. Dakik HA, Howell JF, Lawrie GM, et al. Assessment of myocardial viability with 99mTc-sestamibi tomography before coronary bypass graft surgery: correlation with histopathology and postoperative improvement in cardiac function. Circulation 1997; 96:2892-2898.
40. Gonzalez P, Massardo T, Munoz A, et al. Is the addition of ECG gating to technetium-99m sestamibi SPECT of value in the assessment of myocardial viability? An evaluation based on two-dimensional echocardiography following revascularization. Eur J Nucl Med 1996; 23:1315-1322.
41. Levine MG, McGill CC, Ahlberg AW, et al. Functional assessment with electrocardiographic gated single-photon emission computed tomography improves the ability of technetium-99m sestamibi myocardial perfusion imaging to predict myocardial viability in patients undergoing revascularization. Am J Cardiol 1999; 83:1-5.
42. Maes AF, Borgers M, Flameng W, et al. Assessment of myocardial viability in chronic coronary artery disease using technetium-99m sestamibi SPECT. Correlation with histologic and positron emission tomographic studies and functional follow-up. J Am Coll Cardiol 1997; 29:62-68.
43. Marzullo P, Sambuceti G, Parodi O. The role of sestamibi scintigraphy in the radio- isotopic assessment of myocardial viability. J Nucl Med 1992; 33:1925-1930.
44. Maublant JC, Citron B, Lipiecki J, et al. Rest technetium 99m-sestamibi tomoscintigraphy in hibernating myocardium. Am Heart J 1995; 129:306-314.
45. Bisi G, Sciagra R, Santoro GM, Fazzini PF. Rest technetium-99m sestamibi tomography in combination with short-term administration of nitrates: feasibility and reliability for prediction of postrevascularization outcome of asynergic territories. J Am Coll Cardiol 1994; 24:1282-1289.
46. Bisi G, Sciagra R, Santoro GM, et al. Technetium-99m-sestamibi imaging with nitrate infusion to detect viable hibernating myocardium and predict post-revascularization recovery. J Nucl Med 1995; 36:1994-2000.
47. Greco C, Tanzilli G, Ciavolella M, et al. Nitroglycerin-induced changes in myocardial sestamibi uptake to detect tissue viability: radionuclide comparison before and after revascularization. Coron Artery Dis 1996; 7:877-884.
48. Li ST, Liu XJ, Lu ZL, et al. Quantitative analysis of technetium 99m 2-methoxyisobutyl isonitrile single-photon emission computed tomography and isosorbide dinitrate infusion in assessment of myocardial viability before and after revascularization. J Nucl Cardiol 1996; 3 (6 Pt 1):457-463.
49. Maurea S, Cuocolo A, Soricelli A, et al. Enhanced detection of viable myocardium by technetium-99m-MIBI imaging after nitrate administration in chronic coronary artery disease. J Nucl Med 1995; 36:1945-1952.
50. Schneider CA, Voth E, Gawlich S, et al. Significance of rest technetium-99m sestamibi imaging for the prediction of improvement of left ventricular dysfunction after Q wave myocardial infarction: importance of infarct location adjusted thresholds. J Am Coll Cardiol 1998; 32:648-654.
51. Bax JJ, Visser FC, Poldermans D, et al. Relationship between preoperative viability and postoperative improvement in LVEF and heart failure symptoms. J Nucl Med 2001; 42:79-86.
52. 18F-FDG PET. Eur J Nucl Med Mol Imaging 2006; 33:716-723 This paper demonstrates the prognostic value, with regard to predicting improvement in regional and global left-ventricular function after revascularization and left-ventricular remodeling, of 99mTc-sestamibi/FDG DISA SPECT in direct comparison with PET imaging.
53. Kuhl HP, Lipke CS, Krombach GA, et al. Assessment of reversible myocardial dysfunction in chronic ischaemic heart disease: comparison of contrast-enhanced cardiovascular magnetic resonance and a combined positron emission tomography-single photon emission computed tomography imaging protocol. Eur Heart J 2006; 27:846-853. This paper compares contrast-enhanced CMR and PET/SPECT in predicting regional and global recovery of function after revascularization. Both techniques are similar in predicting a positive response to revascularization. However, CMR was superior at identifying segments unlikely to recover with revascularization.
54. Gursurer M, Emre A, Gercekoglu H, et al. Long-term prognostic value of stress-redistribution-reinjection Tl-201 imaging in patients with severe left ventricular dysfunction and coronary artery bypass surgery. Int J Cardiovasc Imaging 2002; 18:125-133.
55. Pace L, Perrone-Filardi P, Storto G, et al. Prediction of improvement in global left ventricular function in patients with chronic coronary artery disease and impaired left ventricular function: rest thallium-201 SPET versus low-dose dobutamine echocardiography. Eur J Nucl Med 2000; 27:1740-1746.
56. Cuocolo A, Petretta M, Nicolai E, et al. Successful coronary revascularization improves prognosis in patients with previous myocardial infarction and evidence of viable myocardium at thallium-201 imaging. Eur J Nucl Med 1998; 25:60-68.
57. Bax JJ. Assessment of myocardial viability in ischemic cardiomyopathy. Heart Lung Circ 2005; 14 (suppl 2):S8-S13. This paper is a contemporary review of various techniques to assess viability, including data supporting the prognostic value of each of these methods for predicting improvement in regional and global function.
58. Mule JD, Bax JJ, Zingone B, et al. The beneficial effect of revascularization on jeopardized myocardium: reverse remodeling and improved long-term prognosis. Eur J Cardiothorac Surg 2002; 22:426-430.
59. Chikamori T, Hirose K, Hamada T, et al. Functional recovery after coronary artery bypass grafting in patients with severe left ventricular dysfunction and preserved myocardial viability in the left anterior descending arterial territory as assessed by thallium-201 myocardial perfusion imaging. Jpn Circ J 1999; 63:752-758.
60. Passamani E, Davis KB, Gillespie MJ, Killip T. A randomized trial of coronary artery bypass surgery. Survival of patients with a low ejection fraction. N Engl J Med 1985; 312:1665-1671.
61. Pagley PR, Beller GA, Watson DD, et al. Improved outcome after coronary bypass surgery in patients with ischemic cardiomyopathy and residual myocardial viability. Circulation 1997; 96:793-800.
62. Beller GA, Zaret BL. Contributions of nuclear cardiology to diagnosis and prognosis of patients with coronary artery disease. Circulation 2000; 101:1465-1478.
63. Allman KC, Shaw LJ, Hachamovitch R, Udelson JE. Myocardial viability testing and impact of revascularization on prognosis in patients with coronary artery disease and left ventricular dysfunction: a meta-analysis. J Am Coll Cardiol 2002; 39:1151-1158.
64. Gioia G, Powers J, Heo J, Iskandrian AS. Prognostic value of restredistribution tomographic thallium-201 imaging in ischemic cardiomyopathy. Am J Cardiol 1995; 75:759-762.
65. Gioia G, Milan E, Giubbini R, et al. Prognostic value of tomographic rest-redistribution thallium 201 imaging in medically treated patients with coronary artery disease and left ventricular dysfunction. J Nucl Cardiol 1996; 3:150-156.
66. Pasquet A, Robert A, D'Hondt AM, et al. Prognostic value of myocardial ischemia and viability in patients with chronic left ventricular ischemic dysfunction. Circulation 1999; 100:141-148.
67. Petretta M, Cuocolo A, Bonaduce D, et al. Incremental prognostic value of thallium reinjection after stress-redistribution imaging in patients with previous myocardial infarction and left ventricular dysfunction. J Nucl Med 1997; 38:195-200.
68. Abraham WT, Fisher WG, Smith AL, et al. Cardiac resynchronization in chronic heart failure. N Engl J Med 2002; 346:1845-1853.
69. Hummel JP, Lindner JR, Belcik JT, et al. Extent of myocardial viability predicts response to biventricular pacing in ischemic cardiomyopathy. Heart Rhythm 2005; 2:1211-1217. This is the first paper to use a viability test, myocardial contrast perfusion echocardiography, to discriminate responders from nonresponders of CRT. Twenty-one patients who met current CRT criteria underwent myocardial viability testing with contrast echo. The perfusion score index provided an incremental value beyond the tissue Doppler assessment of dyssynchrony in predicting improvement of LVEF.
70. Dobert N, Britten M, Assmus B, et al. Transplantation of progenitor cells after reperfused acute myocardial infarction: evaluation of perfusion and myocardial viability with FDG-PET and thallium SPECT. Eur J Nucl Med Mol Imaging 2004; 31:1146-1151.